- ►208.176.52.104 [PDF] - Free from Publisher EHB Lin, W Katon, M Von Korff, C Rutter, GE … - Diabetes Care, 2004 - Am Diabetes Assoc RESULTS—This predominantly type 2 diabetic population had a mean HbA 1c level
of 7.8 ± 1.6%. Three-quarters of the patients received hypoglycemic agents
(oral or insulin) and reported at least weekly self-monitoring of glucose ... Cited by 202 - Related articles - BL Direct - All 8 versions
- Free from Publisher MB Davidson - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Studies were mainly conducted in two Los Angeles
County clinics. In clinic A, nurse-directed diabetes care was provided to 252
patients (92% Hispanic and 2% African-American) referred by their primary ... Cited by 70 - Related articles - BL Direct - All 6 versions
- Free from Publisher RE Glasgow - Diabetes Care, 2003 - Am Diabetes Assoc Despite these promising advances, it is well documented that there is a large
gap between what is known about diabetes care and what is commonly practiced
(4–6). Studies of the level of diabetes care provided in the real world, ... Cited by 52 - Related articles - BL Direct - All 7 versions
- ►diabetesjournals.org P Suwattee, JC Lynch, ML Pendergrass - Diabetes Care, 2003 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—A cross-sectional medical record review for
patients receiving care between 1 July 2000 and 30 June 2001 was conducted.
Records were abstracted from three practice settings: the Diabetes Clinic ( ... Cited by 43 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org [PDF] G Lepore, AR Dodesini, I Nosari, R Trevisan - Diabetes Care, 2003 - Am Diabetes Assoc Serum IGF-I is reduced in adoles- cents with type 1 diabetes, and in- jections
of IGF-I improve glycemic control (1). The fact that sulfonylureas can increase
IGF-I directly and indepen- dent of insulin has not been included in ... Cited by 36 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org WH Herman, L Kennedy - Diabetes Care, 2005 - Am Diabetes Assoc Diabetic peripheral neuropathy and its late sequelae cost >$4 billion annually
in the US (1). Improved glycemic control, early detection, and preventive care
can prevent or delay adverse outcomes (2–4). An annual foot exam, which ... Cited by 31 - Related articles - All 5 versions
- ►nih.gov CD MacLean, B Littenberg, M Gagnon, M … - Clinical Trials, 2004 - ctj.sagepub.com Background Despite evidence that optimal care for diabetes can result in reduced
complications and improved economic outcomes, such care is often not achieved.
The Vermont Diabetes Information System (VDIS) is a registry-based decision Cited by 31 - Related articles - All 4 versions
AR Rolla, RE Rakel - Clinical therapeutics, 2005 - Elsevier Insulin therapy may eventually be required to maintain glycemic control in many
patients with type 2 diabetes mellitus. Premixed insulin analogues offer
relatively physiologic and predictable time-action profiles and are ... Cited by 27 - Related articles - All 3 versions
